Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Goodwill (2016 - 2018)

Fortress Biotech has reported Goodwill over the past 3 years, most recently at $18.6 million for Q3 2018.

  • Quarterly results put Goodwill at $18.6 million for Q3 2018, changed 0.0% from a year ago — trailing twelve months through Sep 2018 was $18.6 million (changed 0.0% YoY), and the annual figure for FY2017 was $18.6 million, changed 0.0%.
  • Goodwill for Q3 2018 was $18.6 million at Fortress Biotech, roughly flat from $18.6 million in the prior quarter.
  • Over the last five years, Goodwill for FBIO hit a ceiling of $21.7 million in Q3 2016 and a floor of $18.6 million in Q4 2016.
  • Median Goodwill over the past 3 years was $18.6 million (2016), compared with a mean of $19.0 million.
  • Peak annual rise in Goodwill hit 0.0% in 2017, while the deepest fall reached 14.23% in 2017.
  • Fortress Biotech's Goodwill stood at $18.6 million in 2016, then changed by 0.0% to $18.6 million in 2017, then changed by 0.0% to $18.6 million in 2018.
  • The last three reported values for Goodwill were $18.6 million (Q3 2018), $18.6 million (Q2 2018), and $18.6 million (Q1 2018) per Business Quant data.